A Delphi consensus statement for the management of post-COVID interstitial lung disease.
Vijay HaddaTejas Menon SuriHariharan IyerAvinash JainTarun Krishna BoppanaKaran MadanAnant MohanAshu Seith BhallaGirish SindhwaniNaveen DuttKavitha VenkatnarayanAlok NathSahajal DhooriaRohit KumarVikas MarwahSaurabh KarmakarDhruva ChaudhryIrfan Ismail AyubDharm Prakash DwivediTiwari PawanParvaiz KoulAjoy Kumar BeheraPuneet SaxenaAmitabha SenguptaPrasanta Raghab MohapatraAbhishek GoyalDevasahayam J ChristopherRandeep GuleriaPublished in: Expert review of respiratory medicine (2022)
Dedicated facilities should be established for the care of patients with post-COVID ILD. Symptom screening, pulmonary function testing, and thoracic imaging have a role in the diagnosis. The pharmacologic and non-pharmacologic options for the management of post-COVID ILD are discussed. Further research into the pathophysiology and management of post-COVID ILD will improve our understanding of this condition.